Blog Emily Bevis 12/07/2022 Emily Bevis 12/07/2022 mSAS® strategies for enabling simplified formulations Read More Emily Bevis 13/04/2022 Emily Bevis 13/04/2022 mSAS® strategies for enhanced intellectual property Read More Emily Bevis 18/02/2022 Emily Bevis 18/02/2022 Limiting the impact respiratory disease treatments have on the environment Read More Guest User 09/02/2022 Guest User 09/02/2022 mSAS® strategies for the development of natural products Read More Guest User 23/12/2021 Guest User 23/12/2021 Happy holidays from Crystec! Read More Guest User 11/08/2021 Guest User 11/08/2021 Developing biological drugs for inhaled delivery Read More Guest User 21/04/2021 Guest User 21/04/2021 mSAS® strategies for optimised inhaled delivery Read More Guest User 09/02/2021 Guest User 09/02/2021 mSAS® strategies for enhancing the stability of pharmaceutical products Read More Guest User 20/01/2020 Guest User 20/01/2020 mSAS® applications to progress your 2020 drug pipeline Read More Guest User 06/12/2019 Guest User 06/12/2019 mSAS® strategies for addressing poor drug solubility Read More Guest User 25/08/2019 Guest User 25/08/2019 Pharmaceutical Polymorphs Read More Guest User 25/06/2019 Guest User 25/06/2019 Factors influencing inhaled product development Read More LATEST NEWS
Emily Bevis 12/07/2022 Emily Bevis 12/07/2022 mSAS® strategies for enabling simplified formulations Read More
Emily Bevis 13/04/2022 Emily Bevis 13/04/2022 mSAS® strategies for enhanced intellectual property Read More
Emily Bevis 18/02/2022 Emily Bevis 18/02/2022 Limiting the impact respiratory disease treatments have on the environment Read More
Guest User 09/02/2022 Guest User 09/02/2022 mSAS® strategies for the development of natural products Read More
Guest User 11/08/2021 Guest User 11/08/2021 Developing biological drugs for inhaled delivery Read More
Guest User 21/04/2021 Guest User 21/04/2021 mSAS® strategies for optimised inhaled delivery Read More
Guest User 09/02/2021 Guest User 09/02/2021 mSAS® strategies for enhancing the stability of pharmaceutical products Read More
Guest User 20/01/2020 Guest User 20/01/2020 mSAS® applications to progress your 2020 drug pipeline Read More
Guest User 06/12/2019 Guest User 06/12/2019 mSAS® strategies for addressing poor drug solubility Read More
Guest User 25/06/2019 Guest User 25/06/2019 Factors influencing inhaled product development Read More
